Aclaris Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2019 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Aclaris Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to 2023.
  • Aclaris Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.11 USD/shares, a 73.2% increase year-over-year.
  • Aclaris Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.52 USD/shares, a 68.7% increase year-over-year.
  • Aclaris Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.27 USD/shares, a 4.51% increase from 2022.
  • Aclaris Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -1.33 USD/shares, a 16.9% increase from 2021.
  • Aclaris Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -1.6 USD/shares, a 33.3% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1 +$0.06 +4.51% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 -$1 +$0.27 +16.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 -$2 $0 -33.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$1 +$2.70 +69.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$4 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.